The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

Bartholomew County health officials said they are taking a wait-and-see approach after the Trump administration said it plans to limit approval for seasonal COVID-19 shots to seniors and others at ...

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

The US FDA may limit Covid-19 boosters to high-risk groups only, citing lack of efficacy in healthy individuals. Meanwhile, ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.

There is no association between COVID-19 vaccination in pregnancy and spontaneous abortion, according to a study published online.